Roberto Morese

Rome, 00167, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Immune-Related Adverse Events in Patients with Melanoma Treated with B-RAF/MEK Target Therapy: Occurrence and Circulating Immune Cell Analysis.

Immune-Related Adverse Events in Patients with Melanoma Treated with B-RAF/MEK Target Therapy: Occurrence and Circulating Immune Cell Analysis.

Journal: Cancers
Published: February 10, 2026

Case Report: The role of BRAF mutation in adjuvant and neoadjuvant treatment of melanoma patients: what is the optimal approach?

Case Report: The role of BRAF mutation in adjuvant and neoadjuvant treatment of melanoma patients: what is the optimal approach?

Journal: Frontiers in oncology
Published: December 25, 2025

Advanced Cutaneous Squamous Cell Carcinoma: Biology, Immunotherapy, and Evolving Prognostic Factors.

Advanced Cutaneous Squamous Cell Carcinoma: Biology, Immunotherapy, and Evolving Prognostic Factors.

Journal: Biomedicines
Published: November 17, 2025

Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience.

Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience.

Journal: BMC cancer
Published: August 05, 2024

Survival of Patients with Metastatic Melanoma Treated with Ipilimumab after PD-1 Inhibitors: A Single-Center Real-World Study.

Survival of Patients with Metastatic Melanoma Treated with Ipilimumab after PD-1 Inhibitors: A Single-Center Real-World Study.

Journal: Cancers
Published: August 05, 2024

Case report: Fast disease progression during adjuvant therapy with anti-PD-1 in stage III melanoma patients.

Case report: Fast disease progression during adjuvant therapy with anti-PD-1 in stage III melanoma patients.

Journal: Frontiers in oncology
Published: May 23, 2024

Primary Mucosal Melanoma: Clinical Experience from a Single Italian Center.

Primary Mucosal Melanoma: Clinical Experience from a Single Italian Center.

Journal: Current oncology (Toronto, Ont.)
Published: December 16, 2023

Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients.

Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients.

Journal: Journal of cancer research and clinical oncology
Published: August 18, 2021

Integrated care pathways and the hub-and-spoke model for the management of non-melanoma skin cancer: A proposal of the Italian Association of Hospital Dermatologists (ADOI).

Integrated care pathways and the hub-and-spoke model for the management of non-melanoma skin cancer: A proposal of the Italian Association of Hospital Dermatologists (ADOI).

Journal: Dermatology reports
Published: May 31, 2021

Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches.

Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches.

Journal: Biomedicines
Published: January 11, 2021

The integrated care pathway for non melanoma skin cancer: the Istituto Dermopatico dell'Immacolata - IRCCS experience in Rome.

The integrated care pathway for non melanoma skin cancer: the Istituto Dermopatico dell'Immacolata - IRCCS experience in Rome.

Journal: Recenti progressi in medicina
Published: December 28, 2020

Efficacy of sonidegib for basal cell carcinoma in a patient affected by multiple infectious diseases.

Efficacy of sonidegib for basal cell carcinoma in a patient affected by multiple infectious diseases.

Journal: Dermatologic therapy
Published: December 16, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026